logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

BEKE-W (02423) spent $1.9991 million to repurchase 344,500 shares on August 31.

date
17:28 01/09/2026
avatar
GMT Eight
Beike-W (02423) announced that on August 31, 2026, the company invested $1.9991 million to repurchase 344,500 shares, with a repurchase price of $5.74 to $5.94 per share.
BEKE-W (02423) announced that on August 31, 2026, the company will spend $1,999,100 to repurchase 344,500 shares, with a repurchase price ranging from $5.74 to $5.94 per share.
Related Articles
HK Stock
QUNABOX GROUP (00917) spent HKD 910,100 on September 1 to repurchase 100,000 shares.
HK Stock
CSPC PHARMA (01093): SYS6010 has been included again in the list of breakthrough therapy varieties by the National Medical Products Administration of China for the treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma.
China Stock
Zhongman Petroleum And Natural Gas Group Corp., Ltd. (603619.SH): Zhu Fengxue plans to reduce his stake by no more than 1.2%.
QUNABOX GROUP (00917) spent HKD 910,100 on September 1 to repurchase 100,000 shares.
HK Stock
CSPC PHARMA (01093): SYS6010 has been included again in the list of breakthrough therapy varieties by the National Medical Products Administration of China for the treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma.
HK Stock
Zhongman Petroleum And Natural Gas Group Corp., Ltd. (603619.SH): Zhu Fengxue plans to reduce his stake by no more than 1.2%.
China Stock
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.